PARBRAZE 150MG TABLET

Form: Tablets

Pack Size: 60 TABLETS

Marketed by: ABBOTT HEALTHCARE PVT LTD (ONCOLOGY DIV)

MRP: ₹5169.33

ABBOTT HEALTHCARE PVT LTD (ONCOLOGY DIV): Parbraze 150MG Tablet, 60 tablets, salt olaparib 150mg. NPPA has revised its MRP from Rs 23,203.13 to Rs 5,169.33 (78% lower) with effect from 09-11-2026; trade rate Rs 3,938.54. Group: PARP inhibitor (targeted therapy). Same salt is also supplied by AstraZeneca, Cipla, Dr. Reddy's, Emcure, Glenmark and others. Handling/counselling: tablet and capsule forms are not interchangeable mg for mg; check the prescription carefully. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.